Mikhail Blagosklonny and Mr. Gudkov are two of the most influential scientists in the world today. The two are colleagues, and they are working as oncologists at the Roswell Park Cancer Institute. Oncologists are people who study the cancer disease, and they are working to find a cure for the disease. Andrei V. Gudkov and Mr. Mikhail noticed that the oncologists around the world lack a platform where they can independently share their discoveries with one another, so they decided to gather the assistance from computer experts and explained how they wanted to offer a solution to the problem. Mikhail Blagosklonny and Gudkov asked the computer experts to create a platform that can save information that will be sent by oncologists around the world, and thus, Oncotarget was born. The computer experts turned Oncotarget into an accessible website because Mr. Blagosklonny and Mr. Gudkov wanted all of the information to be available to the public. Oncotarget was launched in 2010, and it was met with positive reviews both from the public and from the scientists. Listen to Oncotarget podcast on Stitcher.
Since its launch, Oncotarget has been consistently used by scientists around the world. They are using the online medical journal to speak with different oncologists coming from the other side of the world. They are working together by exchanging different discoveries, and they are also reviewing all of the information that is being put inside their reports. The articles that are submitted by scientists, on the other hand, are being reviewed extensively by a team of scientists who are having different specialties. They are the ones who greenlights or blocks an article from being published online. Visit Soundcloud to listen an audio podcast of Oncotarget.
Today, Oncotarget releases two separate articles every week. It can be accessed by going to the official Oncotarget website, and it should be placed on the most recent article tab. Mikhail and Andrei are hoping that the creation of Oncotarget will change the medical industry forever. They wanted the scientists from around the world to work together, because they believe that by working as one, the long overdue cure for cancer can finally be discovered.